Kohn E C
Medicine Branch, National Cancer Institute, Bethesda, MD 20892.
Pharmacol Ther. 1991 Nov;52(2):235-44. doi: 10.1016/0163-7258(91)90011-a.
Metastatic dissemination of tumor is the primary cause of death for most cancer patients. The expanding field of study of the metastatic cascade has been the source of novel approaches to the diagnosis and treatment of cancer. The metastatic process involves angiogenesis, tumor cell adhesion to vascular basement membrane, local proteolysis to create an opening in the basement membrane, migration through that rent and into the secondary site, and finally, successful proliferation. Important components of the metastatic cascade such as basement membrane structures, adhesion molecules and their receptors, proteolytic enzymes, migration-inducing factors, and growth factors have been demonstrated to have reproducible patterns in malignant and metastatic tissues. These patterns have led to clinical correlations demonstrating their utility in the identification and follow-up of malignant and metastatic disease. In addition, several promising new anti-cancer drugs such as inhibitors of angiogenesis, protease-inhibitors, and blockers of signal transduction have been identified and are awaiting introduction into the clinical arena.
肿瘤的转移扩散是大多数癌症患者死亡的主要原因。转移性级联反应这一不断扩展的研究领域已成为癌症诊断和治疗新方法的来源。转移过程涉及血管生成、肿瘤细胞与血管基底膜的黏附、局部蛋白水解以在基底膜上形成开口、通过该裂口迁移至继发部位,以及最终成功增殖。转移性级联反应的重要组成部分,如基底膜结构、黏附分子及其受体、蛋白水解酶、迁移诱导因子和生长因子,已被证明在恶性和转移组织中具有可重复的模式。这些模式已产生临床关联,证明它们在恶性和转移性疾病的识别及随访中的效用。此外,已鉴定出几种有前景的新型抗癌药物,如血管生成抑制剂、蛋白酶抑制剂和信号转导阻滞剂,它们正等待引入临床领域。